Coromandel International Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 8,164.77 Cr (+15.94% YoY) and PAT growth of -24.59% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 23, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 8,164.77 Cr (+15.94% YoY) |
| PAT (Q1) | Rs. 380.82 Cr (-24.59% YoY) |
| EBITDA margin | 9.26% (-185 bps YoY) |
| EPS (Q1) | Rs. 12.93 |
| Market cap | Rs. 59,780.03 Cr |
| CMP | Rs. 2,023.00 |
Coromandel reported strong revenue growth of 15.9% YoY, but profitability declined sharply due to input cost inflation, with EBITDA margin compressing 185 bps and PAT falling 24.6%. The crop protection segment, boosted by the NACL acquisition, showed strong growth but margins were lower than standalone. The core nutrient business faced severe margin pressure from rising raw material costs, and no management guidance was provided to assess forward trajectory.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now